Share Twitter LinkedIn Facebook Email Charles Loprinzi, MD, Regis Professor of Breast Cancer Research, Medical Oncologist at Mayo Foundation for Medical Education and Research at Mayo Clinic. In this video, he speaks about Chemotherapy-Induced Neuropathy: Guidelines and More.
FDA Approves Datopotamab Deruxtecan / Datroway from Eli Lilly in Treatment for Unresectable or Metastatic HR-Positive, HER2-Negative Breast Cancer Breast 2 Mins Read
Can Imlunestrant Change the Future of Breast Cancer Treatment? Insights from SABCS with Virginia Kaklamani, MD Breast 3 Mins Read